STOCKHOLM, Sweden, 1 January 2025
Avia Pharma is announcing its official representation in the Nordics of Theramex, a global specialty pharmaceutical company that specializes in women’s health products.
Based in London, Theramex is a global pharmaceutical company dedicated to Women’s Health in over eighty countries, across five continents. The Group is driven by a vision to be a leader in women’s health care by providing innovative, effective solutions that care for and support women as they advance through each stage of their lives.
This prestigious partnership includes a series of pharmaceuticals within Hormone Replacement Therapy (HRT) and contraceptives.
The representation of Theramex in the Nordics is in line with Avia Pharma’s business growth strategy to grow its core business and explore new opportunities and partnerships.
“This representation also stems from the development of our Women’s Health Business Unit, set to be one of our flagship projects for the coming years,” says Marie Wikman.
“We are excited to partner with Avia Pharma in the Nordics who, like Theramex, share our commitment to women’s health and to improve access to high quality treatments. We look forward to this new collaboration and we are sure that together, we will support many women to live a better and more empowered life,” said Rob Stewart, CEO of Theramex.
“Through our representation of Theramex, Avia Pharma is now going to be even better positioned to provide education and support around important issues and daily realities faced by women every day, including menopause” concludes Marie Wikman.
